Study on the initiation mechanism of higher eukaryotic DNA replication.
高等真核生物DNA复制启动机制的研究。
基本信息
- 批准号:09680669
- 负责人:
- 金额:$ 1.92万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DNA replication from oriP of Epstein-Barr virus is mediated by the virus replication factor EBNA1 and cellular factors. Since the replication occurs only once in each cell cycle, we used oriP as a model replication origin to investigate the molecular machinery for the initiation of DNA replication. First, we have identified the dyad symmetry (DS) element of oriP as a minimal oriP element that is necessary and sufficient for DNA replication. The DS element contains only the four EBNA1-binding sites. This suggests that DNA replication is initiated by recruitment of cellular replication factors onto or near the minimal oriP by EBNA1. We also demonstrate that the oriP plasmid required a cell cycle window including early G1 phase for the replication in next S phase. This suggests that the DS-dependent DNA replication from oriP requires the replication licensing. Consistent with this, MCM2 associates with the oriP minichromosome at late G1 but not at G2/M, and this association requires the DS-element in the plasmid. Interaction of EBNA1 and MCM5 on the DS element is also suggested. From these results, we suggest that the cellular licensing mechanism controls the replication from oriP. We also find that the signal transduction form the EBV-encoded latent membrane protein 1 (LMP1) suppresses oriP. The TRAF-binding motif in LMP1, PxQxT, is essential and sufficient to initiate the signal cascade leading to the suppression of oriP, which is distinct from signal cascades leading to activation of NF-κB, JNK, JAK-stat and MAPKs. Excess expression of TRAF6 with a help of TRAF5 also induces suppression of oriP in the absence of LMP1. Thus, the TRAF-mediating signals from LMP1 and a cellular membrane receptor regulate the oriP's function as a DNA replication origin.
EB病毒oriP的DNA复制由病毒复制因子EBNA 1和细胞因子介导。由于复制在每个细胞周期中只发生一次,我们使用oriP作为模型复制起点来研究DNA复制起始的分子机制。首先,我们已经确定了二分体对称(DS)元素的oriP作为一个最小的oriP元素,是必要的和足够的DNA复制。DS元件仅包含四个EBNA 1结合位点。这表明DNA复制是通过EBNA 1将细胞复制因子募集到最小oriP上或附近而启动的。我们还证明了oriP质粒需要一个细胞周期窗口,包括早期G1期的复制在下一个S期。这表明,DS依赖的DNA复制oriP需要复制许可。与此一致,MCM 2在G1晚期与oriP微型染色体结合,但在G2/M期不结合,这种结合需要质粒中的DS元件。EBNA 1和MCM 5在DS元件上的相互作用也被提出。从这些结果,我们认为,细胞许可机制控制复制从oriP。我们还发现EBV编码的潜伏膜蛋白1(LMP 1)的信号转导抑制oriP。LMP 1中的TRAF结合基序PxQxT对于启动导致oriP抑制的信号级联是必需的且足够的,oriP抑制的信号级联不同于导致NF-κB、JNK、JAK-stat和MAPK活化的信号级联。TRAF 6在TRAF 5的帮助下的过量表达也诱导了在LMP 1不存在的情况下对oriP的抑制。因此,来自LMP 1和细胞膜受体的TRAF介导信号调节oriP作为DNA复制起点的功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masaki Shirakata: "Requirement of replication licensing for the dyad symmetry element-dependent replication of the EBV"Virology. 263. 42-54 (1999)
Masaki Shirakata:“EBV 的二元对称元件依赖性复制的复制许可要求”病毒学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kanji Hirai: "Replication licensing of the EBV oriP minichromosome"Curr. Top. Micro. Imm.. (印刷中).
Kanji Hirai:“EBV oriP 微型染色体的复制许可”Imm..(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H. Shigekane, Y. Kawaguchi, M. Shirakata, M. Sakaguchi, and K. Hirai: "The-bidirectional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 1.8kb-mRNA in the long inverted repeats of Marek's disease virus serotyp
H. Shigekane、Y. Kawaguchi、M. Shirakata、M. Sakaguchi 和 K. Hirai:“用于 pp38/pp24 mRNA 和长反向重复中的 1.8kb-mRNA 的潜伏相关转录本的双向转录启动子
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masaki Shirakata, Ken-Ichi Imadome, and Kanji Hirai.: "Requirement of replication licensing for the dyad symmetry element-dependent replication of the EBV oriP minichromosome."Virology. 263. 42-54 (1999)
Masaki Shirakata、Ken-Ichi Imadome 和 Kanji Hirai.:“EBV oriP 微型染色体的二元对称元件依赖性复制的复制许可要求。”病毒学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Jifen Li: "Major product pp43 of human cytomegalovirus U_L112-113 gene is a transcriptional coactivator"Virology. 260. 89-97 (1999)
李吉芬:“人巨细胞病毒U_L112-113基因的主要产物pp43是转录辅激活因子”病毒学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHIRAKATA Masaki其他文献
SHIRAKATA Masaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHIRAKATA Masaki', 18)}}的其他基金
Regulation of Epstein-Barr virus EBNA1 by signal transduction
通过信号转导调节 Epstein-Barr 病毒 EBNA1
- 批准号:
19590469 - 财政年份:2007
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of Epstein-Barr virus replication by signal transduction
通过信号转导调节 Epstein-Barr 病毒复制
- 批准号:
17590415 - 财政年份:2005
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Signal transduction in cell division
细胞分裂中的信号转导
- 批准号:
15570154 - 财政年份:2003
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
In vitro reconstitution of the replication initiation complex
复制起始复合物的体外重建
- 批准号:
13680757 - 财政年份:2001
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis and the latency of herpes simplex virus
单纯疱疹病毒的潜伏期分析
- 批准号:
11694254 - 财政年份:1999
- 资助金额:
$ 1.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
相似海外基金
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10889325 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Epstein-Barr Virus nuclear antigen leader protein in transcription regulation
Epstein-Barr病毒核抗原前导蛋白在转录调控中的作用
- 批准号:
10829620 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Project 4 - Controlling the Latent-to-Lytic Switch in Epstein-Barr Virus
项目 4 - 控制 Epstein-Barr 病毒中的潜伏至裂解转换
- 批准号:
10910338 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Understanding the immune response changes to clinical interventions for Epstein-Barr virus infection prior to lymphoma development in children after organ transplants (UNEARTH)
了解器官移植后儿童淋巴瘤发展之前针对 Epstein-Barr 病毒感染的临床干预的免疫反应变化(UNEARTH)
- 批准号:
10755205 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Regulation and Functions of the Epstein-Barr Virus Lytic Switch Protein
EB 病毒裂解开关蛋白的调控和功能
- 批准号:
489085 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Operating Grants
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
- 批准号:
10679118 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
- 批准号:
10755055 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Deciphering the Role of Epstein-Barr Virus Molecular Mimicry and B cell Transformation in Multiple Sclerosis
解读 Epstein-Barr 病毒分子拟态和 B 细胞转化在多发性硬化症中的作用
- 批准号:
10568864 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Project 2: Novel investigation of Epstein-Barr virus as a potential cause of conjunctival squamous cell carcinoma among people living with HIV in Zimbabwe
项目 2:对 Epstein-Barr 病毒作为津巴布韦艾滋病毒感染者结膜鳞状细胞癌潜在原因的新调查
- 批准号:
10598376 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:
Project 3 - Characterizing the Amplification Factories of Epstein-Barr Virus and Kaposi's Sarcoma-associated Herpesvirus
项目 3 - 描述 Epstein-Barr 病毒和卡波西肉瘤相关疱疹病毒的扩增工厂
- 批准号:
10910337 - 财政年份:2023
- 资助金额:
$ 1.92万 - 项目类别:














{{item.name}}会员




